T-cell treatment groups with physiological length-spanning IFPs (PTM or CTMΔ12EC) showed no difference in weight change, tumour burden, or survival compared to the untransduced group (Fig. 4b, c, d), confirming their selective function and lack of CAR-independent, PD-L1-driven T cell activation. Here, CD274 is linked to neoplasm.